Progression of renal dysfunction in patients with cardiovascular disease

about

Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

P2860

Q34765857-04DC021C-654A-46FA-8F1A-574128E18F71

P2860

Progression of renal dysfunction in patients with cardiovascular disease

Item

http://www.wikidata.org/entity/Q37429092

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Progression of renal dysfunction in patients with cardiovascular disease

@en

Progression of renal dysfunction in patients with cardiovascular disease.

@nl

type

Item

label

Progression of renal dysfunction in patients with cardiovascular disease

@en

Progression of renal dysfunction in patients with cardiovascular disease.

@nl

prefLabel

Progression of renal dysfunction in patients with cardiovascular disease

@en

Progression of renal dysfunction in patients with cardiovascular disease.

@nl

P1476

Progression of renal dysfunction in patients with cardiovascular disease

@en

P2093

Arihiro Kiyosue

http://www.w3.org/2001/XMLSchema#string

Daisuke Nagata

http://www.w3.org/2001/XMLSchema#string

Etsu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Satonaka

http://www.w3.org/2001/XMLSchema#string

Masataka Sata

http://www.w3.org/2001/XMLSchema#string

Ryozo Nagai

http://www.w3.org/2001/XMLSchema#string

Yasunobu Hirata

http://www.w3.org/2001/XMLSchema#string

P2860

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

End-stage renal disease in African-American and white men. 16-year MRFIT findings.

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?

Lipids and progressive kidney disease.

P304

198-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157340308785160543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masao Takahashi

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40029499

http://www.w3.org/2001/XMLSchema#string

P698

19936196

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

2780821

http://www.w3.org/2001/XMLSchema#string

Progression of renal dysfunction in patients with cardiovascular disease

about

P2860

P2860

Progression of renal dysfunction in patients with cardiovascular disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932